ArticleCureus2025
Monthly Trajectories of Mood Improvement Following a Workplace Mindfulness Programme: A Randomised Controlled Pilot Trial.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMindfulness‑based interventions (MBIs) are widely adopted to mitigate workplace stress, yet their month-by-month impact on mood has rarely been quantified. METHODOLOGY: A total of 25 full‑time Japanese employees (60% men; mean ± SD age 40.1 ± 6.2 years) were randomised to a three‑month MBI arm (n = 12) or a wait‑list control arm (n = 13). The MBI comprised three 90‑min workshops (Weeks 0, 4, 8) plus 10‑min daily self‑practice. Measuring Total Mood Disturbance scores (TMD; POMS‑2‑SF) was the primary outcome; fatigue (100‑mm VAS) and presenteeism (Stanford Presenteeism Questionnaire; SPQ) were secondary. Assessments occurred at baseline and monthly for three months. Linear mixed‑effects models with participant random intercepts tested group × time interactions; 95% bootstrap CIs (1,000 iterations) were generated.
resultsTMD declined cumulatively in the MBI arm (‑4.2, ‑4.4, ‑6.3 points at Months 1‑3), while controls rose +1.0 point; interaction β = ‑2.56 points·month⁻¹ (95 % CI ‑4.31 to ‑0.71, p = 0.014). Fatigue (p = 0.47) and presenteeism (p = 0.41) trends favoured the intervention but were non‑significant.
conclusionsA low‑dose workplace MBI produced additive three‑month reductions in mood disturbance. Monthly assessments clarify change dynamics and justify larger confirmatory trials integrating physiological and organisational endpoints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.